Maha H. Sharawy
Al Mansurah, DK 35516, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Corrigendum to "The modulatory effect of sodium molybdate against cisplatin-induced CKD: Role of TGF-β/Smad signaling pathway" [Life Sci. Volume 306 1 October 2022, 120845].
Journal: Life sciences
Published: June 13, 2026
Corrigendum to "Empagliflozin enhances neuroplasticity in rotenone-induced parkinsonism: Role of BDNF, CREB and Npas4" [Life Sci. 312 (1 January 2023) 121258].
Journal: Life sciences
Published: January 20, 2026
Dexmedetomidine attenuates high-fat diet-induced metabolic dysfunction-associated steatotic liver disease in rats by regulating the autophagic pathway.
Journal: Scientific reports
Published: May 20, 2025
Modulatory Effects of Chrysin on Cadmium-Induced Hepatotoxicity and Testicular Injury in Rats.
Journal: Journal of biochemical and molecular toxicology
Published: April 28, 2025
Inhibition of p75NTR/p53 axis by ambrisentan suppresses apoptosis and oxidative stress-mediated renal damage in a cisplatin AKI model.
Journal: Chemico-biological interactions
Published: November 21, 2024
Aprepitant ameliorates vancomycin-induced kidney injury: Role of GPX4/system Xc- and oxidative damage.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: October 28, 2024
Regulating ferroptosis by roflumilast attenuates cisplatin-induced kidney injury.
Journal: International immunopharmacology
Published: July 22, 2024
Peficitinib halts acute kidney injury via JAK/STAT3 and growth factors immunomodulation.
Journal: European journal of pharmacology
Published: April 18, 2024
Roflumilast extenuates inflammation and oxidative stress in cadmium-induced hepatic and testicular injury in rats.
Journal: International immunopharmacology
Published: June 16, 2023
Corrigendum to "Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia" [Int. Immunopharm. 89(Part A) (2020) 107011].
Journal: International immunopharmacology
Published: March 03, 2023
Nifuroxazide mitigates doxorubicin-induced cardiovascular injury: Insight into oxidative/NLRP3/GSDMD-mediated pyroptotic signaling modulation.
Journal: Life sciences
Published: November 02, 2022
Last Updated: 09/26/2026